Analyst Recommendations

Piper Sandler analyst issues OVERWEIGHT recommendation for TSLA on February 5, 2024 12:22PM ET. The previous analyst recommendation was Overweight.TSLA was trading at $181.5561 at issue of the...

February 5, 2024   TSLA 3.74%

Wells Fargo analyst issues BUY recommendation for NVDA on February 5, 2024 07:00AM ET. The previous analyst recommendation was Buy.NVDA was trading at $661.6 at issue of the...

February 5, 2024   NVDA -0.20%

Goldman Sachs analyst issues OUTPERFORM recommendation for AAPL on February 2, 2024 11:33AM ET. The previous analyst recommendation was Buy.AAPL was trading at $186.28 at issue of the...

February 2, 2024   AAPL -0.38%

Needham analyst issues BUY recommendation for AMZN on February 2, 2024 11:10AM ET. The previous analyst recommendation was Buy.AMZN was trading at $171.06 at issue of the analyst...

February 2, 2024   AMZN 9.58%

KeyBanc analyst issues OVERWEIGHT recommendation for META on February 2, 2024 05:46AM ET. The previous analyst recommendation was Overweight.META was trading at $394.78 at issue of the analyst...

February 2, 2024   META -2.72%

BMO Capital analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -0.31%

Scotiabank analyst issues PERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Sector Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX 2.74%

Raymond James analyst issues OUTPERFORM recommendation for CVX on February 2, 2024 01:06AM ET. The previous analyst recommendation was Outperform.CVX was trading at $147.89 at issue of the...

February 2, 2024   CVX 2.74%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -0.31%

Raymond James analyst issues OUTPERFORM recommendation for MA on February 1, 2024 05:15PM ET. The previous analyst recommendation was Outperform.MA was trading at $460.92 at issue of the...

February 2, 2024   MA -0.31%